Trial Outcomes & Findings for Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery (NCT NCT02588976)

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

Routine measurements during cardiac surgery

Results posted on

2018-05-04

Participant milestones
Measure	ACT Measurements ACT measurements by SONOCLOT Analyzer during cardiac surgery Sonoclot Analyzer: Blood coagulation test during cardiac surgery: Measurement of activated clotting time during cardiac surgery by Sonoclot Analyzer
Overall Study STARTED	30
Overall Study COMPLETED	30
Overall Study NOT COMPLETED	0

Withdrawal data not reported

Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery

Baseline characteristics by cohort
Measure	All Patients n=30 Participants
Age, Categorical <=18 years	0 Participants n=93 Participants
Age, Categorical Between 18 and 65 years	11 Participants n=93 Participants
Age, Categorical >=65 years	19 Participants n=93 Participants
Age, Continuous	67 years STANDARD_DEVIATION 15 • n=93 Participants
Sex: Female, Male Female	16 Participants n=93 Participants
Sex: Female, Male Male	14 Participants n=93 Participants
Region of Enrollment Switzerland	30 Participants n=93 Participants

Timeframe: Routine measurements during cardiac surgery

Outcome measures
Measure	All Patients n=30 Participants
Kaolin-activated Clotting Time	309 seconds Standard Deviation 211

Timeframe: Routine measurements during cardiac surgery

Outcome measures
Measure	All Patients n=30 Participants
Glass Bead Activated Clotting Time	195 seconds Standard Deviation 57

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Triemli City Hospital

Phone: +41 44 416 25 52